Janneke de Boer

CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra, Yuan He, Janneke de Boer et al. · Cancer Immunology Research · 2019 · 38 citations · Full text

The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands

Anne M. Spanjaart, Elise R. A. Pennings, Pim Mutsaers et al. · Cancers · 2023 · 21 citations · Full text

Cell Therapy, Population-based Real-world Data, R/r Lbcl +20

Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities

Janneke de Boer, Kylie Keijzer, Elise R. A. Pennings et al. · Cancers · 2023 · 16 citations · Full text

Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma

Kylie Keijzer, Janneke de Boer, Jaap A. van Doesum et al. · Blood Cancer Journal · 2024 · 15 citations · Full text

Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation

Kylie Keijzer, Anne G.H. Niezink, Janneke de Boer et al. · Computational and Structural Biotechnology Journal · 2023 · 11 citations · Full text